Type I hypersensitivity

Type I Hypersensitivity

Type I Hypersensitivity, commonly referred to as immediate hypersensitivity or an allergic reaction, is the most common type of hypersensitivity reaction. It occurs rapidly after exposure to specific antigens (allergens) to which an individual has become sensitized, leading to an exaggerated immune response mediated by Immunoglobulin E (IgE) antibodies.

Illustration of the mechanism behind a Type I hypersensitivity reaction.

Causes and Pathophysiology

Type I hypersensitivity is triggered by exposure to specific allergens, which can vary widely among individuals. Common allergens include pollen, dust mites, certain foods, insect stings, and medications. Upon first exposure to an allergen, the body's immune system produces IgE antibodies specific to that allergen. Subsequent exposure leads to the binding of the allergen to IgE antibodies on the surface of mast cells and basophils, causing these cells to release inflammatory mediators like histamine, leukotrienes, and prostaglandins.

Clinical Manifestations

The symptoms of Type I hypersensitivity can range from mild to severe and may include: - Rhinitis (hay fever) - Asthma - Dermatitis (eczema) - Urticaria (hives) - Anaphylaxis, a severe, potentially life-threatening reaction characterized by difficulty breathing, a sudden drop in blood pressure, and dizziness or faintness.

Diagnosis

Diagnosis of Type I hypersensitivity typically involves: - Detailed medical history and physical examination - Skin prick tests to identify specific allergens - Blood tests to measure levels of IgE antibodies

Treatment

Treatment options for Type I hypersensitivity aim to alleviate symptoms and prevent severe reactions: - Avoidance of known allergens - Antihistamines to counteract the effects of histamine - Corticosteroids to reduce inflammation - Immunotherapy (allergy shots) to desensitize the immune system to specific allergens - Epinephrine (adrenaline) injections for emergency treatment of anaphylaxis

Prevention

Preventive measures for Type I hypersensitivity focus on minimizing exposure to known allergens. This may involve environmental controls, dietary modifications, and the use of protective measures during high-risk activities (e.g., carrying an epinephrine auto-injector for individuals with known severe allergies).

External Links

• American Academy of Allergy, Asthma & Immunology - Allergies
• World Allergy Organization

References

<references />